These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16199106)

  • 1. Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nano-particles.
    Xiong XY; Tam KC; Gan LH
    J Control Release; 2005 Nov; 108(2-3):263-70. PubMed ID: 16199106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles.
    Xiong XY; Tam KC; Gan LH
    J Control Release; 2005 Mar; 103(1):73-82. PubMed ID: 15710501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein interaction with a Pluronic-modified poly(lactic acid) Langmuir monolayer.
    Kiss E; Dravetzky K; Hill K; Kutnyánszky E; Varga A
    J Colloid Interface Sci; 2008 Sep; 325(2):337-45. PubMed ID: 18649892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of thermosensitive pluronic F127-b-poly(ɛ-caprolactone) mixed micelles.
    Zhou Q; Zhang Z; Chen T; Guo X; Zhou S
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):45-57. PubMed ID: 21489759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets.
    Barreiro-Iglesias R; Bromberg L; Temchenko M; Hatton TA; Alvarez-Lorenzo C; Concheiro A
    Eur J Pharm Sci; 2005 Dec; 26(5):374-85. PubMed ID: 16165345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
    Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
    Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):535-9. PubMed ID: 9876619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of stevioside Pluronic-F-68 copolymer based PLA-nanoparticles as an antidiabetic nanomedicine.
    Barwal I; Sood A; Sharma M; Singh B; Yadav SC
    Colloids Surf B Biointerfaces; 2013 Jan; 101():510-6. PubMed ID: 23022553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.
    Qian F; Tao J; Desikan S; Hussain M; Smith RL
    Pharm Res; 2007 Aug; 24(8):1551-60. PubMed ID: 17380258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers.
    Agrawal SK; Sanabria-DeLong N; Coburn JM; Tew GN; Bhatia SR
    J Control Release; 2006 May; 112(1):64-71. PubMed ID: 16507325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Enzyme-Responsive Capsules of Hyaluronic Acid-block-Poly(Lactic Acid) for Sensing Bacterial Enzymes.
    Tücking KS; Grützner V; Unger RE; Schönherr H
    Macromol Rapid Commun; 2015 Jul; 36(13):1248-54. PubMed ID: 25940300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres.
    Seki T; Kawaguchi T; Endoh H; Ishikawa K; Juni K; Nakano M
    J Pharm Sci; 1990 Nov; 79(11):985-7. PubMed ID: 2149864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on the properties of linear PLA-poloxamer and star PLA-poloxamine copolymers for temporary biomedical applications.
    Leroy A; Pinese C; Bony C; Garric X; Noël D; Nottelet B; Coudane J
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4133-9. PubMed ID: 23910324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nanoparticles prepared with PLA derivatives].
    Onishi H; Machida Y
    Nihon Rinsho; 2006 Feb; 64(2):225-30. PubMed ID: 16454174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanostructures for drug delivery applications based on Pluronic copolymer systems.
    Xiong XY; Tam KC; Gan LH
    J Nanosci Nanotechnol; 2006; 6(9-10):2638-50. PubMed ID: 17048472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of the novel anionic amphiphilic photosensitizer TPCS 2a by nonionic Pluronic block copolymers.
    Lilletvedt M; Smistad G; Tønnesen HH; Høgset A; Kristensen S
    Eur J Pharm Sci; 2011 Jun; 43(3):180-7. PubMed ID: 21530656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pharmaceuticals on the nanoscale structure of PEO-PPO-PEO micelles.
    Sharma PK; Reilly MJ; Jones DN; Robinson PM; Bhatia SR
    Colloids Surf B Biointerfaces; 2008 Jan; 61(1):53-60. PubMed ID: 17728116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.